[HTML] from thejgo.orgM Bouchereau, MK Gervais, L Sideris… - Journal of …, 2011 - thejgo.org Cytoreductive surgery(CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is now becoming a standard of care for peritoneal carcinomatosis (PC) in selected patients. Eradication of macroscopic disease (nodules > 2.5 mm) is realized through meticulous CS. Following CS, ... Related articles - Cached - All 7 versions
EN Parson, S Lentz, G Russell, P Shen… - The American Journal of …, 2011 - Elsevier Few data exist on the treatment of peritoneal surface dissemination (PSD) from ovarian cancer (OC) with hyperthermic intraperitoneal chemotherapy (HIPEC). This work represents a review of the authors' institution's experience with HIPEC for PSD from OC. Related articles - All 2 versions
YLB Klaver, T Hendriks, RMLM Lomme… - Annals of …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Cited by 1 - Related articles - All 5 versions
PH Cashin, W Graf, P Nygren… - Annals of …, 2011 - Eur Soc Med Oncology Background: Cytoreductive surgery and intraperitoneal chemotherapy has improved prognosis in patients with peritoneal carcinomatosis. The main modes of intraperitoneal chemotherapy treatment are peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) and ... Related articles - All 2 versions
M Muller, M Chérel, PF Dupré… - European Surgical …, 2011 - content.karger.com Purpose: Hyperthermic intraperitoneal chemotherapy is continuously under evaluation in ovarian cancer. The purpose of the present study was to evaluate the effect of chemotherapy, drug concentration and temperature. Materials and Methods: A human ovarian carcinoma cell line was used. ... Related articles - All 2 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
